About Siren Biotechnology
Siren Biotechnology is a private company based in San Francisco, California, incorporated in 2020 in Delaware. It has reported $19,611,194 raised in one offering on Form D since April 2024. Its chief executive is Nicole Paulk.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 8, 2024 | Apr 22, 2024 | $19,611,194of $32.4M target | 57 | $344K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Siren Biotechnology's Form D filed Apr 22, 2024.